Selected Publication:
SHR
Neuro
Cancer
Cardio
Lipid
Metab
Microb
Schmidt, HH; Renner, H; Linkesch, W.
Intrapleural instillation of rituximab for the treatment of malignant pleural effusions in NHL.
Haematologica. 2004; 89(11): ECR39-ECR39.
(- Case Report)
[OPEN ACCESS]
PubMed
Google Scholar
- Leading authors Med Uni Graz
-
Schmidt Helmut
- Co-authors Med Uni Graz
-
Linkesch Werner
-
Renner Heiko
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Abstract:
- A patient with CD20(+) leukaemic lymphoplasmacytic Non-Hodgkin's lymphoma (NHL) presented with bilateral malignant pleural effusions. Systemic chemotherapy, repeated percutaneous drainage and bilateral continous chest tube drainage were unable to control the effusions. Rituximab was instilled in a dose-escalating manner via the chest tubes into both pleural spaces, within two weeks the effusions resolved, and the patient has stayed free of symptoms for eight months ongoing. Rituximab may be a promising novel treatment option for malignant effusions in CD20(+) NHL.
- Find related publications in this database (using NLM MeSH Indexing)
-
Antibodies, Monoclonal - therapeutic use
-
Antigens, CD20 - immunology
-
Antineoplastic Agents - therapeutic use
-
Humans -
-
Instillation, Drug -
-
Lymphoma, Non-Hodgkin - complications Lymphoma, Non-Hodgkin - drug therapy Lymphoma, Non-Hodgkin - immunology
-
Male -
-
Middle Aged -
-
Pleura - drug effects
-
Pleural Effusion, Malignant - drug therapy Pleural Effusion, Malignant - etiology Pleural Effusion, Malignant - immunology